Back
Grupo Financiero Banorte SAB de CV Vs. Viking Therapeutics Industry Stock Comparison
Sell
27
GBOOY
Grupo Financiero Banorte SAB de CV
Last Price:
34.33
Seasonality Move:
7.06%
Sell
47
VKTX
Viking Therapeutics
Last Price:
54.13
Seasonality Move:
8.99%
Sell
27
Grupo Financiero Banorte SAB de CV (GBOOY)
is a Sell
Is Grupo Financiero Banorte SAB de CV a Buy, Sell or Hold?
- The current Grupo Financiero Banorte SAB de CV [GBOOY] share price is $34.33. The Score for GBOOY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- GBOOY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $54.16. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GBOOY Stock Price Chart
What is Grupo Financiero Banorte SAB de CV's stock price today?
-
The Grupo Financiero Banorte SAB de CV share price today is $34.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBOOY is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $54.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
GBOOY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.02 | Sell |
Relative Strength Index (14 RSI): | 39.16 | Sell |
Chaikin Money Flow: | -37791 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.2 - 37.18) | Sell |
Bollinger Bands (100): | (36.22 - 48.72) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 40.93 | Sell |
Chaikin Money Flow: | 868119 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.37 - 63.73) | Sell |
Bollinger Bands (100): | (52.14 - 69.1) | Sell |
GBOOY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.4 | Sell |
20-day SMA: | 35.86 | Sell |
50-day SMA: | 38.06 | Sell |
200-day SMA: | 46.6 | Sell |
8-day EMA: | 34.76 | Sell |
20-day EMA: | 35.6 | Sell |
50-day EMA: | 37.91 | Sell |
200-day EMA: | 43.43 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.42 | Sell |
20-day SMA: | 60.55 | Sell |
50-day SMA: | 56.97 | Sell |
200-day SMA: | 50.23 | Buy |
8-day EMA: | 58.53 | Sell |
20-day EMA: | 59.39 | Sell |
50-day EMA: | 58.62 | Sell |
200-day EMA: | 50.21 | Buy |
Grupo Financiero Banorte SAB de CV Earnings Growth & GBOOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.44 per share, and an increase next year of $0.50 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.59 per share.
Grupo Financiero Banorte SAB de CV Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |